| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027526483 |
| P356 | DOI | 10.1038/NG1544 |
| P3181 | OpenCitations bibliographic resource ID | 862043 |
| P698 | PubMed publication ID | 15821736 |
| P5875 | ResearchGate publication ID | 7914538 |
| P50 | author | Lars Klareskog | Q5912759 |
| Juha Kere | Q11867366 | ||
| Cecilia Lindgren | Q30347705 | ||
| Lars Alfredsson | Q30349390 | ||
| Anders Hamsten | Q30421754 | ||
| Per Eriksson | Q37630146 | ||
| Mohsen Khademi | Q41423136 | ||
| Leonid Padyukov | Q42291137 | ||
| Fredrik Piehl | Q56956300 | ||
| Maria Swanberg | Q58034743 | ||
| Anthony J Brookes | Q87461704 | ||
| Maja Jagodic | Q90585165 | ||
| Tomas Olsson | Q100512112 | ||
| P2093 | author name string | Jan Hillert | |
| Holger Luthman | |||
| Eva Akesson | |||
| Pia Lundman | |||
| Ola Börjesson | |||
| Anna Lobell | |||
| Olle Lidman | |||
| P2860 | cites work | Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis | Q22252943 |
| Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) | Q24317711 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease | Q28201947 | ||
| Genetic control of MHC class II expression | Q28216149 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| A comparison of bayesian methods for haplotype reconstruction from population genotype data | Q29547566 | ||
| MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations | Q29616248 | ||
| Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. | Q33886675 | ||
| A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis | Q33982255 | ||
| T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis | Q34321960 | ||
| Transcriptional regulation of the MHC class II antigen presentation pathway | Q35031987 | ||
| Viral inhibition of MHC class II antigen presentation | Q35124245 | ||
| Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases | Q35201241 | ||
| Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study | Q35554431 | ||
| Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class II positive | Q36361537 | ||
| Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects. | Q36500075 | ||
| The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease | Q40684804 | ||
| Modulation of gene expression by the MHC class II transactivator | Q40695550 | ||
| Analysis of the sequence polymorphism within class II transactivator gene promoters | Q40747636 | ||
| Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. | Q40869638 | ||
| DASH-2: flexible, low-cost, and high-throughput SNP genotyping by dynamic allele-specific hybridization on membrane arrays | Q40952681 | ||
| Quantitative control of MHC class II expression by the transactivator CIITA. | Q41055792 | ||
| The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes | Q41322316 | ||
| Class II transactivator regulates the expression of multiple genes involved in antigen presentation | Q41944761 | ||
| The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease | Q43934617 | ||
| Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice | Q44545474 | ||
| Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA). | Q45977020 | ||
| De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. | Q53974447 | ||
| Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis | Q57350588 | ||
| Axotomy induces MHC class I antigen expression on rat nerve cells | Q57352139 | ||
| Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability | Q57426169 | ||
| Human Evidence That the Cystatin C Gene Is Implicated in Focal Progression of Coronary Artery Disease | Q57607723 | ||
| Non-MHC gene regulation of nerve root injury induced spinal cord inflammation and neuron death | Q60057023 | ||
| Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis | Q61709677 | ||
| Discrete gene loci regulate neurodegeneration, lymphocyte infiltration, and major histocompatibility complex class II expression in the CNS | Q63433239 | ||
| Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system | Q69939601 | ||
| Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression | Q71066478 | ||
| Statins as a newly recognized type of immunomodulator | Q73252634 | ||
| Neurodegeneration and glial activation patterns after mechanical nerve injury are differentially regulated by non-MHC genes in congenic inbred rat strains | Q73421852 | ||
| Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3' untranslated region of the major histocompatibility complex class II transactivator gene | Q73734459 | ||
| Harm or heal--divergent effects of autoimmune neuroinflammation? | Q78699957 | ||
| Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes | Q78826844 | ||
| An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci | Q80304627 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| myocardial infarction | Q12152 | ||
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 486–494 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction | |
| P478 | volume | 37 |
| Q35909380 | A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex |
| Q54327866 | A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus. |
| Q33519260 | A search for non-chromosome 6 susceptibility loci contributing to rheumatoid arthritis |
| Q57224275 | Age-dependent variation of genotypes in MHC II transactivator gene (CIITA) in controls and association to type 1 diabetes |
| Q50893300 | Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus. |
| Q37058799 | Antibody deficiency diseases. |
| Q31142214 | Association analysis of positional obesity candidate genes based on integrated data from transcriptomics and linkage analysis |
| Q41258623 | Association between the functional MHC2TA -168 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis |
| Q37005355 | Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis |
| Q50901639 | Association of STAT4 gene polymorphism with increased susceptibility of rheumatoid arthritis in a northern Chinese Han subpopulation. |
| Q83948186 | Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression |
| Q36396428 | Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. |
| Q38396964 | Atherosclerosis in rheumatoid arthritis: is it all about inflammation? |
| Q64084557 | Autoimmunity After Ischemic Stroke and Brain Injury |
| Q37138017 | Autoimmunity in atherosclerosis: a protective response losing control? |
| Q36564419 | Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins. |
| Q36405072 | CATERPILLERs, pyrin and hereditary immunological disorders |
| Q57224319 | CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations |
| Q36253879 | CIITA is not associated with risk of developing rheumatoid arthritis |
| Q33832877 | CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis |
| Q36856825 | CIITA: a master regulator of adaptive immunity shows its innate side in the bone |
| Q35557796 | Cardiovascular co-morbidity in patients with rheumatic diseases. |
| Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
| Q24338643 | Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK. |
| Q38687394 | Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis. |
| Q37289733 | Combined sequence-based and genetic mapping analysis of complex traits in outbred rats |
| Q40283554 | Combined-cross analysis of genome-wide linkage scans for experimental autoimmune encephalomyelitis in rat. |
| Q57537211 | Complexity of a complex disease; understanding genes, environment and immunity in rheumatoid arthritis development |
| Q36049088 | Construction of an integrative regulatory element and variation map of the murine Tst locus. |
| Q42970803 | Current concepts in the genetic diagnostics of rheumatoid arthritis. |
| Q37398076 | Current concepts in the pathogenesis of early rheumatoid arthritis |
| Q87246910 | DNA methylation and mRNA expression of HLA-DQA1 alleles in type 1 diabetes mellitus |
| Q35029916 | Dyslipidaemia in rheumatological autoimmune diseases |
| Q48216277 | Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases. |
| Q58859993 | Evaluation of DLA promoters in Doberman hepatitis |
| Q33467388 | Fine mapping of gene regions regulating neurodegeneration |
| Q38084534 | From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A. |
| Q37231612 | Functions of NOD-Like Receptors in Human Diseases |
| Q36527734 | Genetic Variations of NLR family genes in Behcet's Disease |
| Q36165202 | Genetic markers of cardiovascular disease in rheumatoid arthritis. |
| Q48140109 | Genetic regulation of microglia activation, complement expression, and neurodegeneration in a rat model of traumatic brain injury |
| Q36389322 | Genetic susceptibility to coronary artery disease: from promise to progress. |
| Q36599259 | Genetic susceptibility to myocardial infarction and coronary artery disease |
| Q36866992 | Genetic variability in the rat Aplec C-type lectin gene cluster regulates lymphocyte trafficking and motor neuron survival after traumatic nerve root injury |
| Q30559534 | Genetic variants in platelet factor 4 modulate inflammatory and platelet activation biomarkers |
| Q26801766 | Genetics of autoimmune diseases: insights from population genetics |
| Q36700670 | Genetics of the innate immune response in inflammatory bowel disease |
| Q34007848 | Genome-wide association studies and the problem of relatedness among advanced intercross lines and other highly recombinant populations |
| Q91724331 | Genome-wide association study of peripheral artery disease in the Million Veteran Program |
| Q37283020 | Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases. |
| Q40384936 | Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink |
| Q31121756 | Hereditary immunologic disorders caused by pyrin and cryopyrin |
| Q37246396 | High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis? |
| Q40097941 | Host strain-dependent difference in susceptibility in a rat model of herpes simplex type 1 encephalitis |
| Q57315646 | Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease |
| Q30499032 | Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunity |
| Q34242898 | Identification of a novel gene for diabetic traits in rats, mice, and humans |
| Q33701063 | Identification of candidate risk gene variations by whole-genome sequence analysis of four rat strains commonly used in inflammation research |
| Q37138039 | Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism |
| Q37077947 | Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study |
| Q33324460 | Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study |
| Q43215243 | Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages |
| Q34213779 | Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis |
| Q34259926 | Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesis |
| Q38477579 | Interaction network analysis revealed biomarkers in myocardial infarction |
| Q36930892 | Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations |
| Q24289002 | Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells |
| Q81044319 | Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region |
| Q33717534 | Lack of association of the CIITA -168A→G promoter SNP with myasthenia gravis and its role in autoimmunity |
| Q38235035 | Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis |
| Q41388881 | MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients. |
| Q42871560 | MHC2TA is associated with rheumatoid arthritis in Japanese patients |
| Q36577538 | Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis |
| Q36577423 | Mechanisms of disease: atherosclerosis in autoimmune diseases |
| Q33349615 | Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis |
| Q28265793 | Mini review: immune response to myelin-derived sulfatide and CNS-demyelination |
| Q37419122 | Molecular genetics of atherosclerosis |
| Q36843011 | Molecular genetics of myocardial infarction |
| Q35708039 | Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells |
| Q59831106 | Multiple loci comprising immune-related genes regulate experimental neuroinflammation |
| Q36171871 | Multiple sclerosis genetics: leaving no stone unturned |
| Q60445325 | Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus |
| Q61955081 | NLR functions beyond pathogen recognition |
| Q28580736 | Naturally occurring genetic variability in expression of Gsta4 is associated with differential survival of axotomized rat motoneurons |
| Q36562655 | Naturally occurring variation in the Glutathione-S-Transferase 4 gene determines neurodegeneration after traumatic brain injury |
| Q35120022 | Nonproteolytic roles of 19S ATPases in transcription of CIITApIV genes |
| Q24812542 | On the genetic involvement of apoptosis-related genes in Crohn's disease as revealed by an extended association screen using 245 markers: no evidence for new predisposing factors |
| Q37401601 | P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. |
| Q39444427 | Pathogen-driven selection in the human genome |
| Q37014849 | Pathway analysis of seven common diseases assessed by genome-wide association |
| Q40192191 | Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines. |
| Q39924246 | Personalized medicine in coronary artery disease: insights from genomic research |
| Q33267324 | Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality |
| Q34469229 | Polymorphisms in the inflammatory genes CIITA, CLEC16A and IFNG influence BMD, bone loss and fracture in elderly women |
| Q83095119 | Polymorphisms of the Interferon gamma gene and coronary artery disease in the Korean population |
| Q39436638 | Population Genetics and Natural Selection in Rheumatic Disease |
| Q27001032 | Population genetic tools for dissecting innate immunity in humans |
| Q28200569 | Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies |
| Q37102159 | Primer: SNP-associated studies and what they can teach us. |
| Q36735401 | Primer: comparative genetics of animal models of arthritis--a tool to resolve complexity |
| Q34774643 | Progress and prospects in rat genetics: a community view. |
| Q42409876 | Protective effect of A at position - 168 in the type III promoter of the MHCIITA gene in systemic lupus erythematosus |
| Q98188932 | Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes |
| Q36941912 | Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications |
| Q36274925 | Regulation of MHC class II gene expression by the class II transactivator |
| Q34330648 | Regulation of major histocompatibility complex class II gene expression, genetic variation and disease |
| Q24538382 | Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 |
| Q36843132 | Rheumatoid arthritis and atypical cardiovascular disease: inflammation changing the clinical presentation |
| Q36574986 | Rheumatoid arthritis and the heart |
| Q35759959 | Role of the MHC2TA gene in autoimmune diseases. |
| Q38985750 | Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes |
| Q50318500 | Serum Lipid Alterations in Early Rheumatoid Arthritis Patients on Disease Modifying Anti Rheumatoid Therapy. |
| Q37027316 | Statin treatment for rheumatoid arthritis: a promising novel indication |
| Q37324840 | T cells in rheumatoid arthritis |
| Q45859107 | Targeted gene therapy of autoimmune diseases: advances and prospects |
| Q41727268 | The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females. |
| Q36944315 | The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association |
| Q35605624 | The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients |
| Q28383855 | The PYRIN domain in signal transduction |
| Q35907536 | The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls |
| Q37724190 | The balancing act of autoimmunity: central and peripheral tolerance versus infection control. |
| Q81329256 | The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent distal enhancers |
| Q36096120 | The evolutionary landscape of cytosolic microbial sensors in humans |
| Q24642348 | The expanding genetic overlap between multiple sclerosis and type I diabetes |
| Q38097500 | The genetics of innate immunity sensors and human disease |
| Q36508676 | The immune response in atherosclerosis: a double-edged sword |
| Q34164644 | The immune system in atherosclerosis |
| Q39230390 | The immunology of atherosclerosis |
| Q37206876 | The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus |
| Q36070941 | The rs4774 CIITA missense variant is associated with risk of systemic lupus erythematosus. |
| Q37625670 | Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies |
| Q28591514 | Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis |
| Q38089941 | Vaccines against atherosclerosis |
| Q57224178 | Variability in the CIITA gene interacts with HLA in multiple sclerosis |
| Q37755264 | What does the immunogenetic basis of rheumatoid arthritis teach us about the immunobiology of the disease? |
| Q85069904 | [How do T-cells become activated in joints?] |
Search more.